blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1052989

EP1052989 - USE OF 2-AMINO-6- TRIFLUOROMEHTHOXY- BENZOTHIAZOLE FOR PREVENTING OR TREATING CEREBELLUM DYSFUNCTION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.06.2004
Database last updated on 20.09.2024
Most recent event   Tooltip04.06.2004No opposition filed within time limitpublished on 21.07.2004  [2004/30]
Applicant(s)For all designated states
Aventis Pharma S.A.
20, avenue Raymond Aron
92160 Antony / FR
[2000/47]
Inventor(s)01 / BOHME, Andrees
32, rue Vitruve
F-75020 Paris / FR
02 / BOIREAU, Alain
80, rue Porchefontaine
F-94370 Sucy en Brie / FR
03 / CANTON, Thierry
1, avenue André Toutain
F-93270 Sevran / FR
04 / IMPERATO, Assunta
195 bis, rue Raymond Losserand
F-75014 Paris / FR
[2000/47]
Application number, filing date99901703.103.02.1999
[2000/47]
WO1999FR00230
Priority number, dateFR1998000140206.02.1998         Original published format: FR 9801402
[2000/47]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO9939710
Date:12.08.1999
Language:FR
[1999/32]
Type: A1 Application with search report 
No.:EP1052989
Date:22.11.2000
Language:FR
The application published by WIPO in one of the EPO official languages on 12.08.1999 takes the place of the publication of the European patent application.
[2000/47]
Type: B1 Patent specification 
No.:EP1052989
Date:30.07.2003
Language:FR
[2003/31]
Search report(s)International search report - published on:EP12.08.1999
ClassificationIPC:A61K31/425, A61P21/00, A61P25/14
[2003/01]
CPC:
A61K31/428 (EP,US); A61K31/425 (KR); A61P21/00 (EP);
A61P25/00 (EP); A61P25/14 (EP); A61P43/00 (EP)
Former IPC [2000/47]A61K31/425
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [2000/47]
TitleGerman:VERWENDUNG VON 2-AMINO-6-TRIFLUOROMETHOXYBENZOTHIAZOL ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR VORBEUGUNG ODER BEHANDLUNG VON ZEREBELLUMKRANKHEITEN[2003/05]
English:USE OF 2-AMINO-6- TRIFLUOROMEHTHOXY- BENZOTHIAZOLE FOR PREVENTING OR TREATING CEREBELLUM DYSFUNCTION[2000/47]
French:APPLICATION DU 2-AMINO-6- TRIFLUOROMETHOXY- BENZOTHIAZOLE POUR LA PREVENTION OU LE TRAITEMENT DES DYSFONCTIONNEMENTS DU CERVELET[2000/47]
Former [2000/47]VERWENDUNG VON 2-AMINO-6-TRIFLUOROMETHOXYBENZOTHIAZOLE ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR VORBEUGUNG ODER BEHANDLUNG VON ZEREBELLUMKRANKHEITEN
Entry into regional phase01.08.2000National basic fee paid 
01.08.2000Designation fee(s) paid 
01.08.2000Examination fee paid 
Examination procedure27.08.1999Request for preliminary examination filed
International Preliminary Examining Authority: EP
01.08.2000Examination requested  [2000/47]
25.05.2001Despatch of a communication from the examining division (Time limit: M06)
12.11.2001Reply to a communication from the examining division
15.01.2003Communication of intention to grant the patent
26.05.2003Fee for grant paid
26.05.2003Fee for publishing/printing paid
Opposition(s)04.05.2004No opposition filed within time limit [2004/30]
Fees paidRenewal fee
29.01.2001Renewal fee patent year 03
28.02.2002Renewal fee patent year 04
28.02.2003Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]  - DEBONO ET AL, "electrophysiological studies of the effects of riluzole on purkinje cells in cerebellar slices", BR J PHARMACOL, (1989), vol. 97, page 584, XP002081721 [A] 1-4 * abstract *
 [A]  - DESSI ET AL, "riluzole prevents anoxic injury in cultured cerebellar granule neurons", EUR. J. OF PHARM., (1993), vol. 250, no. 2, pages 325 - 328, XP002081722 [A] 1-4 * abstract *

DOI:   http://dx.doi.org/10.1016/0014-2999(93)90398-2
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.